The Globe and Mail reports in its Wednesday, Sept. 11, edition that Barclays analyst Michael Leithead -- in response to Methanex's acquisition of Amsterdam-based OCI Global's international methanol business in a $2.05-billion deal -- lowered his recommendation for the company to "equal-weight" from "overweight" (all figures U.S.). The Globe's David Leeder writes in the Eye On Equities column that Mr. Leithead gave his share target a $12 trim to $44. Analysts on average target the shares at $57.45. Mr. Leithead says in a note: "Transaction with high strategic rationale; fair (but full) price for low-cost assets. Expect some share weakness on capital allocation/leverage pivot and equity offering." The Globe reported on Feb. 2 and Feb. 22 that Raymond James analyst Steve Hansen had reaffirmed his "outperform" recommendation for Methanex. It was then worth $46.14 and $44.06. The Globe reported on April 26 and June 4 that RBC Capital analyst Nelson Ng had reaffirmed his "sector perform" recommendation for Methanex. The shares could then be had for $48.27 and $50.52.